CVS
CVS Health Corp. · Healthcare · Medical - Healthcare Plans
Momentum-inputs (vergelijkbare managers):
breedte van houders -4.0% ·
aandelenstroom +7.4% ·
netto nieuwe posities -4.2%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 4.62M | $393.86M | +1 | n/a |
| Q2 2026 | 181 | +1 | 951.14M | $98.28B | +4 | −4 |
| Q1 2026 | 184 | -5 | 933.53M | $67.00B | +1 | −7 |
| Q4 2025 | 188 | -1 | 988.04M | $78.39B | +1 | −1 |
| Q3 2025 | 31 | +1 | 672.14M | $50.66B | +1 | −1 |
| Q2 2025 | 28 | +1 | 592.40M | $40.85B | +1 | n/a |
| Q1 2025 | 24 | 0 | 305.08M | $20.66B | +1 | −1 |
| Q4 2024 | 24 | -1 | 290.03M | $13.02B | +1 | −2 |
| Q3 2024 | 24 | +2 | 213.06M | $13.39B | +3 | −1 |
| Q2 2024 | 22 | n/a | 197.40M | $11.65B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 70.11M | +11.2% | $3.15B | 1.8% | ▲ Add | 3 | SEC ↗ |
| 2 | Capital World Investors ✦ | 61.04M | +26.6% | $2.74B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passief) | 56.95M | n/a | $2.56B | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 27.05M | +2.6% | $1.21B | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passief) | 18.70M | +29.6% | $839.57M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 13.37M | +14.2% | $600.02M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Glenview Capital ✦ | 11.95M | 0.0% | $536.29M | 13.6% | Held | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 6.37M | +194.2% | $285.79M | 0.3% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Harris Associates (Oakmark) ✦ | 5.71M | -0.9% | $256.22M | 0.4% | ▼ Trim | 3 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 4.19M | -20.2% | $188.16M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 11 | PRIMECAP Management ✦ | 3.00M | -6.7% | $134.56M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | Fairfax Financial ✦ | 2.71M | Nieuw | $121.74M | 7.8% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 2.67M | -34.2% | $118.56M | 0.2% | ▼ Trim | 3 | SEC ↗ ×5 |
| 14 | Two Sigma Investments ✦ | 1.71M | -46.9% | $76.74M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 1.19M | +2.3% | $53.54M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 1.18M | -68.5% | $53.15M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 684.65K | -53.0% | $30.73M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 18 | Point72 Asset Management ✦ | 431.71K | +8.2% | $19.38M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 230.53K | +119.3% | $10.35M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 220.13K | -1.8% | $9.88M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 21 | Arrowstreet Capital ✦ | 183.15K | -94.0% | $8.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 161.50K | -78.6% | $7.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 143.85K | -11.5% | $6.46M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 81.56K | +10.9% | $3.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Fairfax Financial | $121.74M | 7.8% |
Verlaten
| Third Point | $99.04M | was 1.3% |
| Renaissance Technologies | $60.81M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,848 houders, 1.07B aandelen, $73.55B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.